CompletedPhase 2NCT00931944
Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Knopp Biosciences
- Principal Investigator
- Merit Cudkowicz, M.D., MScNeuroClinical Trials Unit (Massachusetts General Hospital)
- Intervention
- KNS-760704(drug)
- Enrollment
- 74 enrolled
- Eligibility
- 21-80 years · All sexes
- Timeline
- 2009 – 2013
Study locations (19)
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- UCLA, Dept. of Neurology - Neuromuscular/ALS Research Center, Los Angeles, California, United States
- The Forbes Norris MDA/ALS Research Center, San Francisco, California, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Massachusettes General Hospital, Boston, Massachusetts, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Bryan LGH Medical Center East, Lincoln, Nebraska, United States
- Columbia University, Lou Gehrig MDA/ALS Research Center, New York, New York, United States
- SUNY Upstate Medical University, Syracuse, New York, United States
- Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
- Drexel University College Of Medicine, Philadelphia, Pennsylvania, United States
- University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00931944 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia